- Dalbir Singh Sandhu, MD
- Assistant Professor of Medicine, Case Western Reserve University; Director of Endoscopy, Cleveland Clinic, Akron General 1, Akron General Ave, Akron, OH, USA.
Special Issue Introduction
Hepatocellular carcinoma (HCC) is the 5th most common cancer and the third leading cause of cancer related deaths worldwide as estimated by World health Organization. An increased trend in mortality rates related to HCC has been observed in most countries over recent decades. Apart from chronic viral illnesses (Hepatitis B and Hepatitis C) and alcohol liver disease, non-alcoholic fatty liver disease is emerging as an important etiology for the development of HCC. Despite our increased understanding about the molecular pathogenesis of HCC, the diagnosis and management of HCC still poses a challenge to clinicians. Recent years have noted a surge in newer diagnostic modalities (imaging, molecular markers, etc.) for HCC. The treatment approaches including newer molecular targets especially for advanced HCC are also rapidly evolving. This special issue will focus on the new perspectives in the diagnosis and management of HCC.
1. Myron Tong Liver Center, Huntington Medical Research Institutes, Pasadena, CA, USA.
2. Dahlia Kak Liver Center, Huntington Medical Research Institutes, Pasadena, CA, USA.
3. Ishan Garg1, Scott M. Thompson1, Shannon P. Sheedy1, Taofic Mounajjed2, Ashish Khandelwal1, Eric C. Ehman1, Candice A. Bookwalter1, and Sudhakar K. Venkatesh1
1. Department of Radiology, Mayo Clinic College of Medicine, Rochester, MN, USA.
2. Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, MN, USA.
4. Flair José Carrilho Department of Gastroenterology, São Paulo Clínicas Liver Cancer Group, Hospital das Clínicas Complex, Instituto do Cancer do Estado de São Paulo, University of São Paulo School of Medicine, São Paulo, Brazil.
5. Leonardo da Fonseca Medical Oncology, São Paulo Clínicas Liver Cancer Group, Hospital das Clínicas Complex, Instituto do Cancer do Estado de São Paulo, University of São Paulo School of Medicine, São Paulo, Brazil.
6. Premashis Kar Department of Medicine, Maulana Azad Medical College, University of Delhi, New Delhi, India.
7. Manash kumar Sarna Assistant Professor, Department of Biotechnology, Down Town university, Guwahati, India.
8. Giampiero Francica Unità Operativa Ecografia ed Ecointerventistica, Pineta Grande Hospital, Castel Volturno, Italy.
9. Javier Camacho Department of Pharmacology, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Avenida Instituto Politécnico Nacional, Mexico City, Mexico.
10. Regina Lo Department of Pathology, The University of Hong Kong, Queen Mary Hospital, Hong Kong, China.
11. Riccardo Inchingolo Department of Cardiovascular and Thoracic Sciences, Fondazione Policlinico Universitario Agostino Gemelli, Istituto di Ricovero e Cura a Carattere Scientifico, Rome, Italy.
12. Sapna Puppala Department of Radiology, Leeds Teaching Hospital, Leeds LS1 3EX, UK.
13. Monika Pazgan-Simon Department of Infectious Diseases and Hepatology, Wroclaw Medical University, Poland.
14. Syed Haque Department of Pharmacology, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India.
15. Archana Rastogi Department of Pathology, Institute of Liver and Biliary Sciences, New Delhi, India.
16. Gayatri Ramakrishna Additional Professor, Dept. of Molecular & Cellular Medicine, New Delhi, India.
17. Emilio De Raffele Department of Internal Medicine and Surgery (DIMEC), S.Orsola-Malpighi Hospital, Alma Mater Studiorum, University of Bologna, Bologna, Italy.
18. Helma P. Cotrim Programa de Pós-Graduação em Medicina e Saúde - PPGMS, Complexo Universitário Professor Edgard Santos, Rua Augusto Viana, 5o. andar; Canela, Salvador, Bahia, Brazil.
Submission Deadline31 Oct 2019